TIGIT can bind to the receptors CD155 (poliovirus receptor-PVR), CD112 (PVRL2, nectin-2), and CD113 (Nectin-3) in immune cells, non-immune cells, and tumor cells, resulting in T cell activation and suppression of cytotoxicity. Here, NECTIN3 is linked to neoplasm.